Vaccinex (VCNX) Stock Chart & Stock Price History $0.79 -0.03 (-3.66%) As of 08/1/2025 01:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Vaccinex Stock Price Performance The Vaccinex (VCNX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 84.90%, with a year-to-date return of -19.40%. In the past month, the stock has increased 8.21%, reflecting recent market activity. As of the latest close, Vaccinex traded at $0.79 with a market cap of $2.05 million and volume of 305 shares. Five years ago, the stock traded at a split-adjusted price of $1,329.30, representing a 99.94% decrease over that period. At the time, it had a market cap of $105.39 million and a volume of 812 shares. Receive VCNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-10.18%1 Month Performance+8.21%3 Month Performance+18.60%Year-To-Date Performance-19.40%1 Year Performance-84.90%5 Year Performance-99.94% VCNX Stock Chart for Saturday, August, 2, 2025 VCNX Chart by TradingView Vaccinex Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$0.82$0.79-3.66%$0.79$0.79305 shs$2.05 million07/31/2025$0.80$0.82+2.49%$0.82$0.82136 shs$2.13 million07/30/2025$0.70$0.80+14.29%$0.80$0.80177 shs$2.08 million07/29/2025$0.88$0.70-20.40%$0.84$0.701,173 shs$1.82 million07/28/2025$0.71$0.88+23.86%$0.88$0.83979 shs$2.29 million07/25/2025$0.70$0.71+1.43%$0.77$0.712,774 shs$1.85 million07/24/2025$0.99$0.70-29.28%$0.98$0.70693 shs$1.82 million07/23/2025$1.05$0.99-5.64%$1.15$0.5911,758 shs$2.57 million07/22/2025$1.02$1.05+3.01%$1.05$0.59590 shs$2.73 million07/21/2025$0.91$1.02+11.90%$1.02$0.98322 shs$2.65 million Get the Latest News and Ratings for VCNX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$0.88$0.91+3.41%$0.91$0.91202 shs$2.37 million07/17/2025$0.87$0.88+1.15%$0.88$0.88348 shs$2.29 million07/16/2025$0.98$0.87-11.12%$0.87$0.87427 shs$2.26 million07/15/2025$0.97$0.98+0.92%$0.98$0.96554 shs$2.55 million07/14/2025$0.94$0.97+3.19%$0.98$0.65425 shs$2.52 million07/11/2025$0.99$0.94-5.05%$0.94$0.94228 shs$2.44 million07/10/2025$0.89$0.99+11.24%$0.99$0.95625 shs$2.57 million07/09/2025$0.89$0.89$0.89$0.89153 shs$2.31 million07/08/2025$0.80$0.89+11.25%$0.89$0.89153 shs$2.31 million07/07/2025$0.70$0.80+14.37%$0.80$0.704,070 shs$2.08 million07/04/2025$0.70$0.70$0.73$0.581,921 shs$1.82 million07/03/2025$0.73$0.70-4.18%$0.73$0.581,921 shs$1.82 million07/02/2025$0.75$0.73-2.67%$0.75$0.73691 shs$1.90 million07/01/2025$0.73$0.75+2.74%$0.75$0.75117 shs$1.95 million Related Companies BTAI Stock Chart AIMD Stock Chart BFRI Stock Chart LSB Stock Chart PHXM Stock Chart XFOR Stock Chart APRE Stock Chart BMRA Stock Chart IMNN Stock Chart KZIA Stock Chart Receive VCNX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Vaccinex and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:VCNX) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredTrump’s crypto advisor may have revealed the next big crypto opportunityWhile investors chase Bitcoin toward $100K, D.C. insiders are quietly loading up on something else. One of Tru...Weiss Ratings | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredToo busy to trade? Good.Too busy to trade? That might be your edge. This after-hours strategy is built for people who don’t sit at ...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vaccinex, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vaccinex With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VCNX Stock Alerts